Cotargeting of Bcl-2 and Mcl-1 shows promising antileukemic activity against AML cells including those with acquired cytarabine resistance
Author:
Funder
National Natural Science Foundation of China
Publisher
Elsevier BV
Subject
Cancer Research,Cell Biology,Genetics,Hematology,Molecular Biology
Reference22 articles.
1. Management of acute myeloid leukemia (AML) in older patients;Abdallah;Curr Oncol Rep,2020
2. High bcl-2 expression in acute myeloid leukemia cells correlates with CD34 positivity and complete remission rate;Lauria;Leukemia,1997
3. A phase I study of the pan bcl-2 family inhibitor obatoclax mesylate in patients with advanced hematologic malignancies;Schimmer;Clin Cancer Res,2008
4. Targeting the B-cell lymphoma/leukemia 2 family in cancer;Davids;J Clin Oncol,2012
5. Mcl-1 and Bcl-2/Bax ratio are associated with treatment response but not with Rai stage in B-cell chronic lymphocytic leukemia;Saxena;Am J Hematol,2004
Cited by 11 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Anticancer properties and mechanism of action of the fungal nucleoside clitocine and its derivatives;European Journal of Medicinal Chemistry Reports;2024-04
2. Large-scale Pan-cancer Cell Line Screening Identifies Actionable and Effective Drug Combinations;Cancer Discovery;2024-03-08
3. Targeting MCL-1 protein to treat cancer: opportunities and challenges;Frontiers in Oncology;2023-07-31
4. A patent review of selective CDK9 inhibitors in treating cancer;Expert Opinion on Therapeutic Patents;2023-04-03
5. Synergistic activity and mechanism of cytarabine and MCL-1 inhibitor AZD5991 against acute myeloid leukemia;Neoplasma;2023
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3